With the burgeoning interest in groundbreaking treatments for type 2 diabetes and obesity treatment, a careful comparison of Mounjaro and Peggo has become critical. While both medications function through akin mechanisms – modulating glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide bindings – key differences in their com